STAR Registry Listing for
nScribe by Neurula
nScribe by Neurula
nscribe: AI Scribe for Clinical Documentation
Overview
nscribe is an advanced artificial intelligence-driven medical scribing solution engineered to streamline clinical documentation workflows. By automating the capture and structuring of patient-physician interactions, nscribe reduces administrative burdens, minimizes burnout, and accelerates documentation turnaround times for healthcare providers.
Core Capabilities & Features- Automated Audio-to-Text Transcription: Securely records and converts clinical consultations into high-fidelity transcripts tailored to medical terminology and specialties.
- Smart Clinical Note Generation: Automatically extracts key clinical data points (such as Chief Complaint, History of Present Illness, Plan, and Assessment) to draft comprehensive electronic medical record (EMR) notes.
- Regulatory Compliance & Security: Built with robust privacy architectures adhering to strict regional healthcare data regulations and standards.
- EMR Integration Workflow: Seamlessly interfaces with modern clinical platforms to facilitate rapid review, editing, and sign-off by practicing physicians.

Offers an industry-accepted way to document what security controls exist in solutions that include AI components or are AI products. It provides a set of Yes/No questions a cloud consumer and cloud auditor may wish to ask of a cloud provider to ascertain their compliance to the Artificial Intelligence Controls Matrix (AICM).
Information about nScribe by Neurula
Listed Since: 08/02/2026
Listed Since: 08/02/2026
STAR for AI Level 1
AI Controls Matrix

AI CAIQ Self-assessment v1.0.2
Offers an industry-accepted way to document what security controls exist in solutions that include AI components or are AI products. It provides a set of Yes/No questions a cloud consumer and cloud auditor may wish to ask of a cloud provider to ascertain their compliance to the Artificial Intelligence Controls Matrix (AICM).
Created or renewed 1 day ago, on August 02, 2026.